Dr. Shanna Marrinan is Clinical Director at 4C Labs, and Vice Chair of the Cannabis Industry Council Research Committee.   She is also an Independent Consultant, formerly at London School of Hygiene and Tropical Medicine, the Houses of Parliament, and University College London. She has also worked at the Novel Psychoactive Substances Unit, at University of Hertfordshire, and has published internationally on issues of drugs policy, toxicology and pharmacology. Her principle research interests include the therapeutic applications of psychoactive compounds, and is also a member of the Drug Science Medical Psychedelics Working Group.